Adele Finardi

Dr
CSL Behring

Presentation(s):

• VPB1165 - IDEAL study: A real-world assessment of pattern of use and clinical outcomes with recombinant factor IX albumin fusion protein (rIX-FP) in patients with haemophilia B in Italy

  Tuesday, July 12, 2022
  6:30 PM – 7:30 PM